. Also the phenomenon of strong fluorescent spots on the fluorescence images was observed. This always occurred within the first 10 h after injection of AlPcS2. Histological analysis showed a local alteration to the mucosa in 67% of these spots, which was either invasive cancer (29%) or inflammation (38%). These results suggest two different mechanisms of AlPcS2 uptake in tissue, one associated with the presence of generalised dysplasia and another associated with local changes of the epithelial/connective tissue, which is not necessarily specific for tumours.
Photosensitive drugs can be used for therapy and detection of cancer. The therapeutic modality is called photodynamic therapy (PDT) and the detection modality is generally referred to as photodiagnosis or photodetection (PD). After administration, the ideal drug for PDT or PD accumulates preferentially in premalignant or malignant tissue. When illuminated with light of suitable wavelength and dose, the sensitiser can be excited to a singlet state, which may decay to an excited triplet state via 'intersystem crossing'. Subsequently, a cascade of events occurs, whereby the energy of the excited photosensitiser is used to create singlet oxygen from its triplet ground state, as well as free radicals, which induce local tissue necrosis (Henderson and Dougherty, 1992) . Combined with selective illumination, tumour destruction with limited damage to normal tissue is possible. If more photosensitiser is retained in tumour than normal tissue, drug fluorescence can be used for tumour localisation or detection.
The sensitiser mostly used in clinical applications is a derivative of haematoporphyrin (HpD) and commercially available as Photofrin. This drug is far from ideal because it induces skin photosensitivity, which can last up to 8 weeks after administration. Also the fluorescent component of HpD or Photofrin is porphyrin in the monomeric form whereas the porphyrin dimers and oligomers are the photodynamically active components, which makes prediction of therapeutic effects more complex (Kessel, 1982; Dougherty, 1987) . Therefore other drugs such as sulphonated metallophthalocyanines (MPcSn, n = 1-4) are under investigation for use as photosensitisers in PDT (Rosenthal, 1991; Van Lier and Spikes, 1989) . These dyes have several favourable characteristics over HpD such as chemical stability, a high absorption of deeply penetrating red light and a relatively low induced skin photosensitivity (Tralau et al., 1989) . A high skin photosensitivity induced by metallophthalocyanines has been reported only for caesium phthalocyanine sulphonate (CePcS) .
In general, the photochemical properties of the phthalocyanines are determined by the central metal ion. Zinc and aluminium have been proposed as suitable central metals for phthalocyanines used for PDT because of the high triplet yield and fluorescence yield (Ambroz et al., 1991; Berg et al., 1989) . The insolubility of the bare phthalocyanine molecule in saline hampers its use in biological systems, but this problem can be overcome by sulphonation. The degree of sulphonation and the position of the sulphonate groups is of importance for the behaviour of the phthalocyanine molecule (hydrophilic, amphiphilic or lipophilic) in biological systems. Sulphonation influences the amount of uptake and the localisation in the cell (Paquette et al., 1988; Peng et al., 1991a; Chan et al., 1990) . Mono-sulphonated phthalocyanines seem to be less attractive as tumour localisers but yield substantial PDT-induced necrosis whereas tetra-sulphonated phthalocyanines are good tumour localisers but yield limited tissue damage (Van Leengoed, 1993; Berg et al., 1989) . However, it was recently found that tetra-sulphonated zinc phthalocyanine showed a doubling of PDT-induced tumour necrosis by changing the illumination wavelength to 692 nm, according to an observed red shift in the absorption spectrum (Griffiths et al., 1994) . Among these sulphonated metallophthalocyanines, aluminum phthalocyanine disulphonate (AlPcS2) seems an interesting compound. In vitro studies show uptake of AlPcS2 in cells and a substantial cytotoxicity (Peng et al., 1991a; Chan et al., 1991) . In vivo studies on the effect of the central metal ion and degree of sulphonation show that AlPcS2 displays a high tumour fluorescence and an adequate tumour necrosis after illumination (Van Leengoed, 1993) . AlPcS2 seems a possible alternative for HpD as a sensitiser for clinical PDT owing to its tumour-localising and photodynamic properties and is therefore interesting for further investigations.
Most in vivo fluorescence studies were performed with animal models in which xenografts were used to mimic the clinical situation. It is known that differences exist between the actual clinical situation and the tumour xenografts such as the presence of a fibrous layer surrounding the implanted material or other host responses (Fodstat, 1988) . A tumour model that has a human counterpart will have the advantage of being clinically comparable. It has been shown that porphyrins accumulate in chemically induced premalignant and malignant tissues in animals ). The tumour model used in the present study is based on the induction of squamous cell carcinomas with 4-nitroquinoline 1-oxide (4NQO) in the hard palate of the rat and closely resembles the clinical and histological appearance of human squamous cell carcinoma (Nauta et al., 1995; Prime et al., 1986) . When 4NQO is applied three times a week, welldifferentiated squamous cell carcinomas will develop within 26 weeks. During the application period tumours are preceded by dysplasia of the oral epithelium that varies from slight to severe, and is correlated with the duration of the application period. The whole mucosal area between the molars is dysplastic and tumours arise locally, sometimes in multiple spots. When the 4NQO application is continued more tumours arise and the existing tumours expand.
To detect sensitiser fluorescence in vivo several systems have been developed that include endoscopes connected to devices like intensified CCD cameras or photomultipliers (Profio et al., 1983; Andersson et al., 1987; Brodbeck et al., 1987; Rogers et al., 1990 Imaging system, AlPcS2 excitation and fluorescence detection A schematic drawing and description of the palatoscope developed for the purpose of illumination and acquisition of fluorescence images is presented in Figure 1 . The region of interest was the mucosa of the hard palate between the molars of the rat. With this endoscope a fairly homogenous beam was obtained, which illuminated an area of approximately 1 cm in diameter. From the centre of the beam the light intensity gradually diminished to not less than 90% at the outer part of the beam. The imaging system projected a full-screen view of the hard palate, including the molars and allowed detailed analysis of the mucosa. The images were digitised by a personal computer-based framegrabber and averaged over 16 frames (Van Leengoed, 1993) . The detection range of the charge coupled device (CCD) camera was between 0 and 30 nW cm-2, and fluorescence was detected in the linear part of the range between 10 and 25 nW cm-2. The images were analysed by imaging software (IAS) using a pixel measurement program that allows measurement of grey-scale values of fields of interest and subtraction of different recorded images. The technique of dual wavelength excitation (Baumgartner et al., 1987) was used to detect the AlPcS2 fluorescence. The AlPcS2 as purchased showed a typical aluminum phthalocyanine absorbance spectrum in the monomeric form with a minimal absorbance between 400 nm and 550 nm followed by a small peak at 590 nm to 615 nm and a large absorbance peak at 672 nm ( Figure 2 ). Since the monomeric form is responsible for phthalocyanine fluorescence it was expected that AlPcS2 fluorescence in vivo could be excited at a wavelength around 610 nm. In pilot experiments we found that autofluorescence images of the palate excited at 460+20 nm combined with a high-pass dichroic mirror (DM) of 550 nm and at 610+15 nm combined with a high-pass DM transmitting light above 650 nm did not differ very much in fluorescence intensity and pattern when the fluorescence of both excitation wavelengths was detected at 675+ 15 nm. After subtraction of the images of the two wavelengths, less than 10% of the original value remained (Figure 3 ). Also the autofluorescence images obtained at 460+20 nm did not alter after drug injection (Figure 3 ), whereas when excited at 610+15 nm AlPcS2 fluorescence was easily detected at a dose of 1 4umol kg-'.
Satisfactory fluorescence intensities for recording images were obtained with light generated by a halogen-lamp (Ha) with an irradiance of 0.2 mW cm-2, after passing through the excitation filter. The power of the lamp was checked regularly during the experiments but no adjustments were necessary.
Experimental procedure and assessment criteria Squamous cell carcinomas and dysplasia were induced by an application of 4NQO three times a week. The rats were briefly anaesthetised by a mixture of nitrous oxide-oxygenhalotane and painted with 4NQO on the mucosa of the hard palate. During the application period the rats were housed under standard housing conditions. For 2, 4, 6, 8, 10, 24, 32, 52, 72 , 100 h after injection. The rats were sacrificed with an intracardial overdose of pentobarbital after the last fluorescence image was recorded. The palate with the surrounding hard and soft tissues, including the skull, were removed in one piece. The palates were fixed in 4% formalin, decalcified with 25% formic acid with 0.34 M trisodium citrate dihydrate for approximately 4 weeks. The degree of decalcification was checked by X-ray analysis. Punch biopsies of 3 mm in diameter (Biopsy Punch, Stiefel, Germany) were taken at locations that displayed as strong fluorescent spots (hotspots) in the fluorescence image or that were clinically suspect for squamous cell carcinomas but did not fluoresce. The palates and biopsies were cut transversely and processed for standard haematoxylin-and eosin-stained histological sections. The slides of the biopsies and the adjacent epithelium in the palatal mucosa were examined by light microscopy and the epithelial dysplasia was assessed according to the epithelium atypia index (EAI) grading list by Smith-Pindborg by an independent observer (PGJN), without knowledge of 4NQO treatment time or of the outcome of the fluorescence measurements (Smith and Pindborg, 1969) .
The average grey-scale value of the total area between the molars at every fluorescence recording after subtraction of autofluorescence was measured for all rats. The grey-scale values of the fluorescent hotspots were measured and compared with the total area measurements. Results Fluorescence intensities and EAI of palates The images of normal rat palate had a typical AlPcS2 fluorescence pattern. A small band along the molars fluoresces strongly and the intensities decrease in the middle of the palate. This was also seen in the 4NQO-treated rats and this pattern slightly interfered with the diagnosis of hotspots because it made the interpretation of the images more complex (Figure 3 ). We were able to reduce the autofluorescence signal to a negligible level of approximately 5 pixels for all groups (0 h) by subtracting the 610 nm and 460 nm images. The greyscale levels of AlPcS2 fluorescence after subtraction were for the normal rats (with the lowest AlPcS2 fluorescence of all groups) approximately 80 pixels. Therefore analysis of AlPcS2 localisation was not hindered by autofluorescence. Two rats that were treated for 8 and 26 weeks respectively with 4NQO were lost during the experimental procedure. The fluorescence intensity of AlPcS2 increased with increasing 4NQO treatment. Figure 4a shows the course of the detected AIPcS2 fluorescence of the mucosa between the molars of a rat treated for 26 weeks with 4NQO. As hotspots were only present between 2 and 10 h after injection it was decided to restrict statistical analysis to that period. No hotspots were observed 24 h after injection. The area under the curve as presented in Figure 4a , between 2 and 10 h should give a good impression of the fluorescence kinetics of tumour tissue. The area was approximated by means of a weighted sum of the fluorescence measurements at times 2, 4, 6, 8 and 10 h respectively using 'weights' 1, 2, 2, 2 Iigure 4b shows the approximated areas vs the number s of 4NQO application for every rat. An extension of ,oxon rank-sum test (Cuzick, 1985; Stepniewska and 1992) was used to confirm a positive trend between under the curve (between 2 and 10 h for all rats) and ber of weeks of 4NQO application (P<0.04). Figure  s the EA indices vs the 4NQO application period. As .ected, a highly significant relationship is present the 4NQO application period and the EAI )n of Wilcoxon rank-sum test; P<0.001). In Figure   pproximated areas vs the EAI is plotted. The EAI was for assessing the severity of the dysplasia and has a m score of 44, but invasive squamous cell carcinoma vas not included in the grading system. We did not SCC from the data analysis since it is an important of the model. It was previously observed that the a induced in this model will eventually lead to invasive or these reasons we assigned the number 50 for all SCC. The size of this number is arbitrary, however; this number between for instance 50 and 100 does not e outcome of the analysis as the essence of the test is of rank-order. The approximated areas under the s the EAI showed a positive trend (extension of In rank-sum test; P<0.05). increase in fluorescence cannot be explained by is in the individual amount of AlPcS2 administered D differences in weight. The rats in each group were For different periods with a possibility of allowing the treatment group (26 weeks) to gain more weight. In Figure 5 the average weight per group is plotted. Initially, the weight increased with prolonged treatment due to ageing, but the body weight of the rats in the group that were treated for 26 weeks was lower than the 20 weeks or 16 weeks groups, although the 26 weeks group had the highest fluorescence intensities. These rats probably lost weight as a result of their malignancy. 4NQO treatment period (weeks) Figure 5 Average weight of the rats ordered per treatment group. The weight increases slightly due to ageing. However, the 26 weeks treatment group, which were the oldest rats and showed the highest fluorescence intensities, weighed less than the 20 weeks or 16 weeks group. level of fluorescence differs per spot as well as the time interval between administration of AlPcS2 and the peak levels. Some hotspots had their maximum at 2 h and some at 4 or 8 h after injection. This did not only occur among different rats but also on the palate of an individual rat. A total of 21 hotspots were seen in the complete group. The fluorescence intensities of the hotspots varied considerably. The average intensity of the hotspots was 135% (s.d+22%) of the fluorescence intensities of total palatal area measurements in a range of 108-215%. The intensity of the spot did not reveal information about a possible malignancy. This wide range indicates that the decision about whether something can be considered a fluorescent spot can only be made on visual information, guided by the fluorescence pattern on screen.
Fluorescence intensities and EAI of biopsies
Six of the 21 hotspots proved to be invasive squamous cell carcinoma. In another eight biopsies inflammation was present. In most cases the inflammation was caused by included hairs or dietary fibres, and macrophages, lymphocytes and foreign body giant cells were present (Figure 7) . Possibly the dysplastic mucosa is easily penetrated by such fibres. In seven of the fluorescent hotspots no specific alterations were found histologically. The EAI number did not differ from the EAI number of the surrounding palatal mucosa in these biopsies. By this biopsy method a sensitivity of 67% was achieved but a tumour specificity of only 29% when squamous cell carcinoma and inflammation were regarded as alterations to the mucosa. In three rats squamous cell carcinomas were found in areas where no hotspots were seen, resulting in 15% false negatives. The spots that represented squamous cell carcinoma were not always clinically suspect for invasive cancer (Figure 8 ).
Discussion
In this study we found that it is possible to localise squamous cell carcinomas induced by 4NQO with AlPcS2-mediated fluorescence. AlPcS2 proved to be a sensitive probe for alterations to the mucosa but not very tumour specific, as only 29% of the biopsies were squamous cell carcinoma. However, when the grade of dysplasia increased, the fluorescence intensities of whole palates increased as well. The EAI (or the 4NQO application period) increased monotonically with the AlPcS2 fluorescence. There is an optimum time interval for the detection of hotspots in mucosa between 2 and 10 h after injection. After this interval AlPcS2 fluorescence could still be detected, up to 1 week after injection, but did not selectively localise in tumour tissue. The technique of dual wavelength excitation is suitable for fluorescence detection of AlPcS2. Tumours on the palate induced by 4NQO have a high production of keratin and this creates a high background fluorescence on the image. By choosing the excitation wavelengths properly it was relatively easy to reduce the (keratin) autofluorescence to an insignificant level. The photochemical properties of phthalocyanines are mainly determined by the macrocycle . Therefore this technique can be applied independently of the number of sulphonate groups.
The AlPcS2 fluorescence detected in this experiment is composed of three levels: (1) non-specific fluorescence of AlPcS2 present in the vessels, connective tissue and normal epithelial tissue; (2) AlPcS2 fluorescence in dysplastic/ neoplastic epithelial tissue; and (3) small areas with high fluorescence intensities displayed as hotspots on fluorescence images. Regarding the second fluorescence level, a significant relation was found in this experimental set-up between the fluorescence intensities of whole palates and an increasing severity of dysplasia. However, to be able to discriminate between normal tissue and dysplastic tissue by numerical Figure 8 Photograph from the palate of rat no. 1 (2 x). The arrow indicates the area of the hotspot as seen on the fluorescence image in Figure 6, (Jori, 1993; Ricchelli et al., 1991; Ben-Hur et al., 1987) . Which of these is the most prominent or whether other unknown pathways are responsible for sensitiser uptake remains to be established (Hamblin and Newman, 1994 ). An increasing turnover rate and the accompanying high lipid metabolism of dysplastic cells possibly leads to a higher phthalocyanine uptake as seen in rats with a higher EAI number. However the phenomenon of the spot fluorescence, which occurred as a result of a high local accumulation of AlPcS2, we interpret as follows: hotspots seem to arise as a result of the improved availability of AlPcS2 to the epithelial cells owing to loss of biological barriers like the basal membrane. By (micro)infiltration of tumour cells into the stroma or mechanical destruction and inflammation, the process of the AlPcS2 uptake can be much more efficient for epithelial cells in areas where the barrier is lost. Likewise a higher uptake of AlPc in tumours has been correlated with the presence of greater vessel permeability (Roberts and Hasan, 1993; Poon et al., 1992) . Also the insertion of polyvinyl sponges induces a high accumulation of porphyrins in these sponges (Straight and Spikes, 1985) . It has often been mentioned that the mechanism for the localisation of sensitisers in tumours is based upon a longer retention time of a sensitiser in tumour tissue than in normal tissue. Based on the kinetics of the complete palate analysis and the spot localisations seen in this study we conclude that more AlPcS2 is taken up by tumour or dysplastic epithelium than by normal epithelium but is also more rapidly cleared from the tumour than from the normal (underlying) tissue. Tumour uptake and clearance of sensitisers probably depends on the type of tumour, the mechanism of tumour induction (autologous or xenograft) and its anatomical location (Chan et al., 1989) . Possibly, the results from this study are only accurate for epithelial disorders and other abnormalities (for instance sarcomas) at the palate may interact differently with AlPcS2.
An important question is whether an optimum interval determined by fluorescence represents the best time interval for PDT treatment of tumours. The results of this study would suggest a time interval of 4-10 h after injection may yield optimal tumour necrosis while sparing the normal tissue as much as possible. However, we expect it to be difficult to induce necrosis solely in tumour tissue because of high normal tissue levels of AlPcS2. In most studies of PDT effects the time interval for illumination of AlPcS2 was chosen at 24 h after injection but not all fluorescence kinetic studies show an optimal uptake of sensitiser at that point Biolo et al., 1991; Peng et al., 1991b; Barr et al., 1991; Pope et al., 1991; Van Leengoed, 1993) . In fact, the maximum uptake in tumour tissue varies from 1 h to 48 h after injection, probably depending largely on the type of tumour and tumour-host tissues which are being studied.
In conclusion, AlPcS2 can be used for photodiagnosis of premalignant and malignant disorders in epithelium and a fluorescence optimum can be expected between 2 and 10 h after injection. It would be interesting to study the possible influence of the time interval between injection and illumination on the selectivity of PDT-induced tumour necrosis.
Abbreviations HpD, haematoporphyrin derivative; AlPcS2, aluminium phthalocyanine disulphonate; 4NQO, 4-nitroquinoline 1-oxide; EAI, epithelial atypia index; DM, dichroic mirror; BPF, bandpass filter.
